Abstract
Aldose reductase (AR) inhibition provides a viable pharmacologically direct mode for the treatment of diabetic complications. We have synthesized a series of N-4 substituted analogues (15-21) of the known aldose reductase inhibitor phenyl-sulfonylnitromethane. The compounds are potent inhibitors of AR with IC50s between 0.01 and 0.19 μM. Some of the compounds are also potent affinity labels for AR. Compound 19 exhibits the highest and almost complete irreversible inhibition of AR known to date.
Original language | English (US) |
---|---|
Pages (from-to) | 745-751 |
Number of pages | 7 |
Journal | European Journal of Medicinal Chemistry |
Volume | 34 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1999 |
Externally published | Yes |
Keywords
- Aldose reductase
- Aldose reductase inhibitors
- Diabetic complication
- Irreversible inhibitors
- Phenylsulphonyl- nitromethane
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
- Organic Chemistry